Beck Capital Management LLC Takes Position in SPDR S&P Biotech ETF $XBI

Beck Capital Management LLC bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 21,801 shares of the exchange traded fund’s stock, valued at approximately $2,658,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. AQR Capital Management LLC increased its holdings in SPDR S&P Biotech ETF by 77.1% in the 1st quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock worth $404,000 after acquiring an additional 2,167 shares in the last quarter. Marshall Wace LLP lifted its holdings in SPDR S&P Biotech ETF by 102.3% during the second quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock valued at $334,000 after purchasing an additional 179,029 shares in the last quarter. The Manufacturers Life Insurance Company acquired a new stake in shares of SPDR S&P Biotech ETF in the second quarter valued at about $260,000. Ameriprise Financial Inc. grew its position in shares of SPDR S&P Biotech ETF by 123.0% in the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock valued at $72,542,000 after purchasing an additional 481,408 shares during the period. Finally, EP Wealth Advisors LLC increased its stake in shares of SPDR S&P Biotech ETF by 3.7% during the second quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock worth $446,000 after purchasing an additional 193 shares in the last quarter.

SPDR S&P Biotech ETF Stock Up 0.8%

XBI opened at $133.79 on Friday. The company has a market cap of $8.54 billion, a PE ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a twelve month low of $80.90 and a twelve month high of $139.19. The company has a 50-day moving average price of $132.63 and a 200 day moving average price of $127.12.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.